マーケットレポート詳細

子宮内膜症治療の世界市場:2034年予測

Endometriosis Treatment Market (Treatment Type: Pain Medication and Hormone Therapy, and Drug Class: Hormonal Contraceptives, Gonadotropin-releasing Hormone (Gn-RH) Agonists and Antagonists) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版元:Transparency Market Research  出版元について
発行年:2024年6月
定価:Single User License $5795 Multi User License $8795 Corporate User License $11795
ご請求は円換算(お見積り日TTSレート)となります。
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
納品形態:PDF by Email
当調査レポートは英文 156ページになります。
商品コード:TMR290

お問い合わせは、アイコンをクリックしてご入力ください。別タブでフォームが開きます。

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

report_image

子宮内膜症の世界市場規模は2023年で14億ドル、2034年に31億ドル、市場の平均年成長率は7.5%にて増加する見込みです。

当レポートでは、子宮内膜症の市場予測-2034年、各種セグメント別市場分析(治療タイプ別、薬剤クラス別、国地域別、等)、市場ダイナミクス、パイプライン分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。


【レポート構成概要】
■子宮内膜症の世界市場予測2020-2034年
・市場規模(US$)

■治療タイプ別、市場-2034年
・鎮痛剤
・ホルモン療法
※(市場規模US$) 

■薬剤クラス別、市場-2034年
・ホルモン避妊薬
・性腺刺激ホルモン放出ホルモン(Gn-RH)作動薬/拮抗薬
・黄体ホルモン療法
・アロマターゼ阻害薬
※(市場規模US$) 

■流通チャネル別、市場-2034年
・病院薬局
・小売薬局
・その他
※(市場規模US$) 

■主要国地域別市場-2034年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析
市場ダイナミクス
パイプライン分析
主要製品/ブランド分析
主要な合併、買収

■子宮内膜症の主要企業プロフィール動向
AbbVie Inc.
AstraZeneca plc
Bayer AG
Ferring Pharmaceuticals
Johnson & Johnson
Myovant Sciences Ltd.
Pfizer Inc.
武田薬品工業株式会社
Lannett Co Inc
Teva Pharmaceutical Industries Ltd.
(全156頁)

Table of Contents (英文詳細目次)

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Endometriosis Treatment Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Endometriosis Treatment Market Analysis and Forecast, 2020-2034

5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Endometriosis Treatment Market Analysis and Forecast, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Treatment Type, 2020-2034
6.3.1. Pain Medication
6.3.2. Hormone Therapy
6.4. Market Attractiveness Analysis, by Treatment Type

7. Global Endometriosis Treatment Market Analysis and Forecast, by Drug Class
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Drug Class, 2020-2034
7.3.1. Hormonal Contraceptives
7.3.2. Gonadotropin-releasing Hormone (Gn-RH) Agonists and Antagonists
7.3.3. Progestin Therapy
7.3.4. Aromatase Inhibitors
7.4. Market Attractiveness Analysis, by Drug Class

8. Global Endometriosis Treatment Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2020-2034
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Others
8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Endometriosis Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Endometriosis Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Treatment Type, 2020-2034
10.3.1. Pain Medication
10.3.2. Hormone Therapy
10.4. Market Value Forecast, by Drug Class, 2020-2034
10.4.1. Hormonal Contraceptives
10.4.2. Gonadotropin-releasing Hormone (Gn-RH) Agonists and Antagonists
10.4.3. Progestin Therapy
10.4.4. Aromatase Inhibitors
10.5. Market Value Forecast, by Distribution Channel, 2020-2034
10.5.1. Hospital Pharmacies
10.5.2. Retail Pharmacies
10.5.3. Others
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Treatment Type
10.7.2. By Drug Class
10.7.3. By Distribution Channel
10.7.4. By Country

11. Europe Endometriosis Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Treatment Type, 2020-2034
11.3.1. Pain Medication
11.3.2. Hormone Therapy
11.4. Market Value Forecast, by Drug Class, 2020-2034
11.4.1. Hormonal Contraceptives
11.4.2. Gonadotropin-releasing Hormone (Gn-RH) Agonists and Antagonists
11.4.3. Progestin Therapy
11.4.4. Aromatase Inhibitors
11.5. Market Value Forecast, by Distribution Channel, 2020-2034
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Treatment Type
11.7.2. By Drug Class
11.7.3. By Distribution Channel
11.7.4. By Country/Sub-region

12. Asia Pacific Endometriosis Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Treatment Type, 2020-2034
12.3.1. Pain Medication
12.3.2. Hormone Therapy
12.4. Market Value Forecast, by Drug Class, 2020-2034
12.4.1. Hormonal Contraceptives
12.4.2. Gonadotropin-releasing Hormone (Gn-RH) Agonists and Antagonists
12.4.3. Progestin Therapy
12.4.4. Aromatase Inhibitors
12.5. Market Value Forecast, by Distribution Channel, 2020-2034
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Treatment Type
12.7.2. By Drug Class
12.7.3. By Distribution Channel
12.7.4. By Country/Sub-region

13. Latin America Endometriosis Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Treatment Type, 2020-2034
13.3.1. Pain Medication
13.3.2. Hormone Therapy
13.4. Market Value Forecast, by Drug Class, 2020-2034
13.4.1. Hormonal Contraceptives
13.4.2. Gonadotropin-releasing Hormone (Gn-RH) Agonists and Antagonists
13.4.3. Progestin Therapy
13.4.4. Aromatase Inhibitors
13.5. Market Value Forecast, by Distribution Channel, 2020-2034
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Treatment Type
13.7.2. By Drug Class
13.7.3. By Distribution Channel
13.7.4. By Country/Sub-region

14. Middle East & Africa Endometriosis Treatment Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Treatment Type, 2020-2034
14.3.1. Pain Medication
14.3.2. Hormone Therapy
14.4. Market Value Forecast, by Drug Class, 2020-2034
14.4.1. Hormonal Contraceptives
14.4.2. Gonadotropin-releasing Hormone (Gn-RH) Agonists and Antagonists
14.4.3. Progestin Therapy
14.4.4. Aromatase Inhibitors
14.5. Market Value Forecast, by Distribution Channel, 2020-2034
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Treatment Type
14.7.2. By Drug Class
14.7.3. By Distribution Channel
14.7.4. By Country/Sub-region

15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. AbbVie Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. AstraZeneca plc
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Bayer AG
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Ferring Pharmaceuticals
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Johnson & Johnson
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Myovant Sciences Ltd.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Pfizer Inc.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. The Takeda Pharmaceutical Company Limited
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Lannett Co Inc
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Teva Pharmaceutical Industries Ltd.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview

List of Tables

Table 01: Global Endometriosis Treatment Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034

Table 02: Global Endometriosis Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034

Table 03: Global Endometriosis Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034

Table 04: Global Endometriosis Treatment Market Size (US$ Bn) Forecast, by Region, 2020-2034

Table 05: North America Endometriosis Treatment Market Size (US$ Bn) Forecast, by Country, 2020-2034

Table 06: North America Endometriosis Treatment Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034

Table 07: North America Endometriosis Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034

Table 08: North America Endometriosis Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034

Table 09: Europe Endometriosis Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 10: Europe Endometriosis Treatment Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034

Table 11: Europe Endometriosis Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034

Table 12: Europe Endometriosis Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034

Table 13: Asia Pacific Endometriosis Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 14: Asia Pacific Endometriosis Treatment Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034

Table 15: Asia Pacific Endometriosis Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034

Table 16: Asia Pacific Endometriosis Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034

Table 17: Latin America Endometriosis Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 18: Latin America Endometriosis Treatment Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034

Table 19: Latin America Endometriosis Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034

Table 20: Latin America Endometriosis Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034

Table 21: Middle East & Africa Endometriosis Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 22: Middle East & Africa Endometriosis Treatment Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034

Table 23: Middle East & Africa Endometriosis Treatment Market Size (US$ Bn) Forecast, by Drug Class, 2020-2034

Table 24: Middle East & Africa Endometriosis Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034

List of Figures

Figure 01: Global Endometriosis Treatment Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034

Figure 02: Global Endometriosis Treatment Market Revenue (US$ Bn), by Treatment Type, 2023

Figure 03: Global Endometriosis Treatment Market Value Share, by Treatment Type, 2023

Figure 04: Global Endometriosis Treatment Market Revenue (US$ Bn), by Drug Class, 2023

Figure 05: Global Endometriosis Treatment Market Value Share, by Drug Class, 2023

Figure 06: Global Endometriosis Treatment Market Revenue (US$ Bn), by Distribution Channel, 2023

Figure 07: Global Endometriosis Treatment Market Value Share, by Distribution Channel, 2023

Figure 08: Global Endometriosis Treatment Market Value Share, by Region, 2023

Figure 09: Global Endometriosis Treatment Market Value (US$ Bn) Forecast, 2020-2034

Figure 10: Global Endometriosis Treatment Market Value Share Analysis, by Treatment Type, 2023 and 2034

Figure 11: Global Endometriosis Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 12: Global Endometriosis Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 13: Global Endometriosis Treatment Market Attractiveness Analysis, by Drug Class, 2024-2034

Figure 14: Global Endometriosis Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 15: Global Endometriosis Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 16: Global Endometriosis Treatment Market Value Share Analysis, by Region, 2023 and 2034

Figure 17: Global Endometriosis Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 18: North America Endometriosis Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 19: North America Endometriosis Treatment Market Attractiveness Analysis, by Country, 2020-2034

Figure 20: North America Endometriosis Treatment Market Value Share Analysis, by Country, 2023 and 2034

Figure 21: North America Endometriosis Treatment Market Value Share Analysis, by Treatment Type, 2023 and 2034

Figure 22: North America Endometriosis Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 23: North America Endometriosis Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 24: North America Endometriosis Treatment Market Attractiveness Analysis, by Region, 2020-2034

Figure 25: North America Endometriosis Treatment Market Attractiveness Analysis, by Drug Class, 2020-2034

Figure 26: North America Endometriosis Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2034

Figure 27: Europe Endometriosis Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 28: Europe Endometriosis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2034

Figure 29: Europe Endometriosis Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 30: Europe Endometriosis Treatment Market Value Share Analysis, by Treatment Type, 2023 and 2034

Figure 31: Europe Endometriosis Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 32: Europe Endometriosis Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 33: Europe Endometriosis Treatment Market Attractiveness Analysis, by Region, 2020-2034

Figure 34: Europe Endometriosis Treatment Market Attractiveness Analysis, by Drug Class, 2020-2034

Figure 35: Europe Endometriosis Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2034

Figure 36: Asia Pacific Endometriosis Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 37: Asia Pacific Endometriosis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2034

Figure 38: Asia Pacific Endometriosis Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 39: Asia Pacific Endometriosis Treatment Market Value Share Analysis, by Treatment Type, 2023 and 2034

Figure 40: Asia Pacific Endometriosis Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 41: Asia Pacific Endometriosis Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 42: Asia Pacific Endometriosis Treatment Market Attractiveness Analysis, by Region, 2020-2034

Figure 43: Asia Pacific Endometriosis Treatment Market Attractiveness Analysis, by Drug Class, 2020-2034

Figure 44: Asia Pacific Endometriosis Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2034

Figure 45: Latin America Endometriosis Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 46: Latin America Endometriosis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2034

Figure 47: Latin America Endometriosis Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 48: Latin America Endometriosis Treatment Market Value Share Analysis, by Treatment Type, 2023 and 2034

Figure 49: Latin America Endometriosis Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 50: Latin America Endometriosis Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 51: Latin America Endometriosis Treatment Market Attractiveness Analysis, by Region, 2020-2034

Figure 52: Latin America Endometriosis Treatment Market Attractiveness Analysis, by Drug Class, 2020-2034

Figure 53: Latin America Endometriosis Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2034

Figure 54: Middle East & Africa Endometriosis Treatment Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 55: Middle East & Africa Endometriosis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2034

Figure 56: Middle East & Africa Endometriosis Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 57: Middle East & Africa Endometriosis Treatment Market Value Share Analysis, by Treatment Type, 2023 and 2034

Figure 58: Middle East & Africa Endometriosis Treatment Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 59: Middle East & Africa Endometriosis Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 60: Middle East & Africa Endometriosis Treatment Market Attractiveness Analysis, by Region, 2020-2034

Figure 61: Middle East & Africa Endometriosis Treatment Market Attractiveness Analysis, by Drug Class, 2020-2034

Figure 62: Middle East & Africa Endometriosis Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2034

△ 一番上に戻る